Quest Diagnostics Proxy Statement Filed
Ticker: DGX · Form: DEF 14A · Filed: Apr 4, 2025 · CIK: 1022079
| Field | Detail |
|---|---|
| Company | Quest Diagnostics Inc (DGX) |
| Form Type | DEF 14A |
| Filed Date | Apr 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting, auditor
Related Tickers: DGX
TL;DR
Quest Proxy filed: vote on directors & auditors for 2025.
AI Summary
Quest Diagnostics Inc. filed its definitive proxy statement on April 4, 2025, for its annual meeting on May 15, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key areas include the election of directors and the ratification of PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and financial oversight, impacting the company's strategic direction and shareholder value.
Risk Assessment
Risk Level: low — This is a routine annual filing providing information to shareholders and does not indicate any immediate financial distress or significant operational changes.
Key Players & Entities
- Quest Diagnostics Inc. (company) — Registrant
- PricewaterhouseCoopers LLP (company) — Proposed independent auditor
- April 4, 2025 (date) — Filing date
- May 15, 2025 (date) — Annual meeting date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting, including details on director nominations, executive compensation, and proposals for shareholder votes, such as ratifying the independent auditor.
When is the annual meeting of shareholders scheduled?
The annual meeting of shareholders is scheduled for May 15, 2025.
Who is proposed to be Quest Diagnostics' independent registered public accounting firm for the upcoming fiscal year?
PricewaterhouseCoopers LLP is proposed to be ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 4, 2025.
What is the company's fiscal year end?
Quest Diagnostics' fiscal year ends on December 31.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 4, 2025 regarding QUEST DIAGNOSTICS INC (DGX).